The Alzheimer’s Foundation of America (AFA) will host an inaugural “Together for Care” telethon on December 4, marking the major focus of a comprehensive campaign by AFA to rally the nation to address this escalating health crisis and prepare to care for the projected surge in the number of Americans with Alzheimer’s disease in addition to the millions of families currently affected by it.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/alzheimers-foundation-of-america/46456/
Each year, more than 51 million school hours are lost as a result of problems related to tooth decay, the most common chronic childhood disease in America.1 Yet according to a recent survey by Trident®, more than eight in 10 (84%) American parents don’t realize this.2 That is why Trident, in partnership with Oral Health America’s Smiles Across America® program (SAA), and actor Chris O’Donnell announced today in Los Angeles that they are teaming up to help fight cavities among the nation’s youth and address the need for oral disease prevention services.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/trident/45632/
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
Northwestern Mutual’s latest Cost of Long-Term Care study, released today, reveals consistently high costs for home health care, assisted living and nursing home care across the nation, underscoring the critical need to address long-term care as part of financial security planning.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53641-northwestern-mutual-cost-of-long-term-care-study-caregiving
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
The View’s Elisabeth Hasselbeck hosted the eighth-annual More Magazine | Fitness Magazine Women’s Half-Marathon in Central Park on April 3rd. More and Fitness magazines in partnership with New York Road Runners, welcomed nearly 10,000 runners for the biggest women’s-only half marathon in the country. Hasselbeck also participated in the race, running her first half marathon with her own Team Nogii to raise money for Celiac Disease research, an autoimmune disease from which she suffers. Hasselbeck finished with a time of 1:44:32.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/more-fitnessmagazine/48499/
The Arthritis Foundation is joining a global effort on Oct. 12, World Arthritis Day, to increase awareness of the many forms of arthritis and to call on individuals and policymakers to take action to reduce the burden of arthritis around the world.
Arthritis affects several hundred million people worldwide. In the United States, it’s the nation’s leading cause of disability, affecting one in five adults (50 million). The disease exacts a hefty financial toll, costing the U.S. economy $128 billion annually. As the staggering prevalence of arthritis continues to rise, the Arthritis Foundation is calling on the nation and individuals to “Move to Improve” to reduce the severe health and economic effects of this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52066-ad-council-world-arthritis-day-move-to-improve-october-12
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced plans to launch its new epilepsy-focused educational website, www.Epilog.us, at the American Epilepsy Society (AES) annual meeting, December 3-5, 2011. The new website will be featured at the Upsher-Smith booth (# 102) and marks an important landmark in the Company’s commitment to the epilepsy community.
To view Multimedia News Release go to http://www.multivu.com/mnr/53440-upsher-smith-launches-new-epilepsy-focused-website
Ortho Clinical Diagnostics (OCD), in partnership with the National Association of Chronic Disease Directors (NACDD), today unveiled new consumer survey results and a report revealing the state of blood test health literacy in the United States with strategies to support much-needed patient education and empowerment. The first step: ensuring patient access to and understanding of blood test results, a critical component to maintaining health and wellness. The campaign kicks off during National Health Literacy Month, an awareness effort founded in 1999 to promote the importance of understandable health information.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52662-ortho-clinical-diagnostics-and-nacdd-blood-test-health-literacy-survey
www.bms-onkologie.de ist die unternehmensbezogene „Heimat“ von Bristol-Myers Squibb Onkologie und bietet für Fachkreise und Öffentlichkeit seit September 2011 neben einem Einblick in Forschung und Entwicklung auch Aktuelles zu verschiedenen onkologischen Erkrankungen. Herzstück ist eine Mediathek mit multimedialen Inhalten unterteilt in „News“, „Veröffentlichungen“, „Veranstaltungen“ und „Austausch“.
www.melanom-wissen.de ist eine Disease Awareness Website zum Thema Melanom (Schwarzer Hautkrebs). Sie bietet Interessierten umfassende Hinweise zu Risikofaktoren und Prävention sowie hilfreiche Informationen und Serviceangebote nach Diagnosestellung.
http://multivu.prnewswire.com/mnr/prne/bristolmyers/52774/
As the season turns from fall to winter, many holiday displays replace pop-up flu vaccine clinics. Yet flu season is not over — it has barely begun. In the 35 years that the Centers for Disease Control and Prevention (CDC) has monitored influenza, February has been the most common month for peak flu activity, including during the 2010-2011 flu season. To share this important information and educate families around the country, Families Fighting Flu is joining the CDC once again during the annual National Influenza Vaccination Week (NIVW) — an observance to promote the importance of flu vaccination as the single best preventative measure against this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52236-families-fighting-flu-psa-flu-survivor-luke-duvall-flu-prevention
On May 27, CVS/pharmacy launched a new in-store fundraising campaign named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis (ALS) and cystic fibrosis (CF). Funds raised through the campaign will benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research, and the Cystic Fibrosis Foundation, the world’s leader in the search for a cure for cystic fibrosis. Supporters for the 2012 campaign can donate $1 or $3 dollars at the register in CVS/pharmacy locations and online at www.cvs.com/alscff through June 30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56330-cvs-pharmacy-fundraising-campaign-support-als-and-cystic-fibrosis
